Ignite Creation Date:
2024-05-05 @ 7:12 PM
Last Modification Date:
2024-10-26 @ 9:45 AM
Study NCT ID:
NCT00627380
Status:
COMPLETED
Last Update Posted:
2010-07-26
First Post:
2008-02-28
Brief Title:
Yoga for the Management of HIV-Metabolic Syndromes
Sponsor:
Washington University School of Medicine
Organization:
Washington University School of Medicine
Study Overview
Official Title:
Yoga for the Management of HIV-Metabolic Syndromes
Status:
COMPLETED
Status Verified Date:
2010-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
We are testing the safety and efficacy of a 16-wk yoga lifestyle intervention on oral glucose tolerance fasting lipidlipoprotein levels body composition cardiovascular function quality of life CD4 T-cell counts and viral load in HIV-infected men and women with components of The Metabolic Syndrome We hypothesize that a yoga lifestyle intervention will improve metabolic anthropometric cardiovascular disease parameters and quality of life domains without adversely affecting immune or virologic status in people living with HIV
Detailed Description:
Very few safe effective and novel treatments for metabolic syndromes that develop in HIV-infected people exist These metabolic syndromes may increase cardiovascular disease risk in HIV-infected people and may reduce their quantity and quality of life Practicing a yoga lifestyle intervention may provide a safe effective and novel therapy for HIV metabolic syndromes but this alternative form of therapy has not been tested in HIV-infected people with metabolic syndromes In men and women with HIV-related metabolic syndromes we will determine
1 The safety of practicing a yoga lifestyle in HIV-infected people treated with HAART who are experiencing metabolic and anthropometric syndromes
2 To quantify the effects of practicing a yoga lifestyle on metabolic and anthropomorphic syndromes in HIV-infected people treated with HAART who are experiencing these syndromes
3 To quantify the effects of practicing a yoga lifestyle on cardiovascular disease CVD risk in HIV-infected people treated with HAART who are at increased CVD risk because of existing metabolic and anthropomorphic syndromes
1 The safety of practicing a yoga lifestyle in HIV-infected people treated with HAART who are experiencing metabolic and anthropometric syndromes
2 To quantify the effects of practicing a yoga lifestyle on metabolic and anthropomorphic syndromes in HIV-infected people treated with HAART who are experiencing these syndromes
3 To quantify the effects of practicing a yoga lifestyle on cardiovascular disease CVD risk in HIV-infected people treated with HAART who are at increased CVD risk because of existing metabolic and anthropomorphic syndromes
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R21AT003083 | NIH | None | None |
| WU187 | US NIH GrantContract | None | httpsreporternihgovquickSearchR21AT003083 |